EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Lysozyme activated co-delivery of latanoprost–timolol from mucoadhesive chitosan nanocomposite to manage glaucoma

B. N. Kumara, R. Shambhu, Yoon-Bo Shim, K. Sudhakara Prasad

RSC Pharmaceutics · 2024 · 1 (3) · 548-569

DOI: 10.1039/d4pm00031e ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Pharmaceutics, 2024. Verfasst von B. N. Kumara und 3 weiteren Autor:innen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Science and Engineering Research Board.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lysozyme, the enzyme found in tears, activates delivery of the anti-glaucoma drugs latanoprost and timolol from mucoadhesive chitosan nanocomposites through the cleavage of β-1,4 glycosidic bonds.

Förderung

  • Science and Engineering Research Board

Zitieren

APA

Kumara, B. N., Shambhu, R., Shim, Y., & Prasad, K. S. (2024). Lysozyme activated co-delivery of latanoprost–timolol from mucoadhesive chitosan nanocomposite to manage glaucoma. RSC Pharmaceutics, 1(3), 548-569. https://doi.org/10.1039/d4pm00031e

Vancouver

Kumara BN, Shambhu R, Shim Y, Prasad KS. Lysozyme activated co-delivery of latanoprost–timolol from mucoadhesive chitosan nanocomposite to manage glaucoma. RSC Pharmaceutics. 2024;1(3):548-569. doi:10.1039/d4pm00031e

BibTeX
@article{Kumara2024,
  author = {Kumara, B. N. and Shambhu, R. and Shim, Yoon-Bo and Prasad, K. Sudhakara},
  title = {Lysozyme activated co-delivery of latanoprost–timolol from mucoadhesive chitosan nanocomposite to manage glaucoma},
  journal = {RSC Pharmaceutics},
  year = {2024},
  volume = {1},
  number = {3},
  pages = {548--569},
  doi = {10.1039/d4pm00031e}
}
Kostenlos starten →